The Recall Desk
LowFDA (Drugs)·D-1392-2020·Announced 2020-07-29

HF Acquisition Recalls Famotidine Injection Due to Temperature Abuse

HF Acquisition Co. LLC is recalling specific lots of Famotidine Injection because a customer reported the product was received in a non-refrigerated state.

What this means for you

Cosmetic or documentation issue. No expected health impact, but the manufacturer is correcting the affected products.

Our severity reasoning: The recall is classified as FDA Class III, which the rubric defines as unlikely to cause adverse health consequences, and no illnesses or injuries are reported.

Plain-English summary

HF Acquisition Co. LLC is recalling Famotidine Injection, USP, 20 mg/2mL, 2 mL vials. The recall was initiated after a complaint was received from a customer stating that the product was received in a non-refrigerated state.

The affected product is identified by Lot # 6122639 with an expiration date of 08/2021. The vials were distributed to one consignee located in Connecticut.

Consumers and healthcare providers should stop using the affected product and contact HF Acquisition Co. LLC for further instructions or a replacement.

The recalled product

Product
FAMOTIDINE (FAMOTIDINE)
Brand
FAMOTIDINE

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (2)

  • Lot #: 6122639
  • Exp. Date 08/2021

UPCs (1)

  • 0363323739119

Distribution

Distributed in 1 state: